JWCA
AMPH icon

J.W. Cole Advisors’s Amphastar Pharmaceuticals AMPH Stock Holding History

J.W. Cole Advisors’s Portfolio AMPH Stock Details AMPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-10,922
Closed -$628K – 737
2023
Q2 		$628K Buy
+10,922
New +$484K 0.04% 367

Other funds holding AMPH

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

J.W. Cole Advisors's AMPH Position: Q3 2023 in Review

J.W. Cole Advisors sold out of Amphastar Pharmaceuticals (AMPH) in Q3 2023, closing a stake of 10,922 shares — an estimated $628K sold.

J.W. Cole Advisors first reported a position in AMPH in Q2 2023 and held it in 1 quarter. The position peaked at $628K in Q2 2023. 255 funds tracked by Wall St. Rank hold AMPH as of Q3 2023.

  • J.W. Cole Advisors reported no remaining Amphastar Pharmaceuticals position as of Q3 2023 after selling out during the quarter.
  • J.W. Cole Advisors sold 10,922 Amphastar Pharmaceuticals shares in Q3 2023, an estimated $628K.
  • J.W. Cole Advisors first reported a position in Amphastar Pharmaceuticals in Q2 2023 and held it in 1 quarter.
  • J.W. Cole Advisors's Amphastar Pharmaceuticals position peaked at $628K in Q2 2023.
  • 255 funds tracked by Wall St. Rank held Amphastar Pharmaceuticals as of Q3 2023.

Based on J.W. Cole Advisors's 13F filing for Q3 2023, filed 24 Oct 2023.